Ledger, P.W.

vaccine influenza study subject 50 mg gmdp side-effects influenza vaccine nursing home residents number intervention vaccination variable symptom titre post-vaccination 4 weeks resident nursing group 3 days blood cell counts regression erasmus university rotterdam 1 day table serum antibody titres adjuvant study population pre-vaccination titres disease antibody fever participant intake count increase condition post-vaccination titres blood virus administration double-blind elsevier leucocyte volume netherland 25 mg dose-dependent increase palache 5 years neutrophils gender double-blind conditions antibody response influenza immunization influenza vaccination dose groups response effect monocyte inconvenience trivalent status parameter subunit 50 mg dose methods intake procedure dementia 50 mg n-acetylglucosaminyl-n-acetylmuramyl-dip double-blind placebocontrolled study vi &/y epidemiol table 1 gmdp population post-vaccination endpoint variables season pre-vaccination rednes blood cell parameters favourable antibody response terminal stage disease